A detailed history of Principal Financial Group Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 27,088 shares of MCRB stock, worth $19,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,088
Previous 61,664 56.07%
Holding current value
$19,503
Previous $86,000 76.74%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$0.75 - $1.56 $25,932 - $53,938
-34,576 Reduced 56.07%
27,088 $20,000
Q4 2023

Feb 07, 2024

BUY
$0.93 - $2.15 $7,180 - $16,600
7,721 Added 14.31%
61,664 $86,000
Q3 2023

Nov 02, 2023

BUY
$2.33 - $5.07 $20,359 - $44,301
8,738 Added 19.33%
53,943 $128,000
Q2 2023

Aug 07, 2023

BUY
$4.67 - $6.55 $37,420 - $52,485
8,013 Added 21.54%
45,205 $216,000
Q1 2023

May 09, 2023

SELL
$4.95 - $6.09 $22,081 - $27,167
-4,461 Reduced 10.71%
37,192 $210,000
Q4 2022

Feb 09, 2023

BUY
$5.09 - $9.05 $105,724 - $187,977
20,771 Added 99.47%
41,653 $233,000
Q3 2022

Nov 09, 2022

SELL
$3.5 - $7.2 $1,263 - $2,599
-361 Reduced 1.7%
20,882 $134,000
Q2 2022

Aug 10, 2022

SELL
$2.7 - $7.62 $4,897 - $13,822
-1,814 Reduced 7.87%
21,243 $73,000
Q1 2022

May 09, 2022

BUY
$6.3 - $8.84 $1,984 - $2,784
315 Added 1.39%
23,057 $164,000
Q4 2021

Feb 09, 2022

SELL
$6.02 - $11.43 $62,595 - $118,849
-10,398 Reduced 31.38%
22,742 $189,000
Q3 2021

Nov 09, 2021

SELL
$5.46 - $22.6 $133,109 - $550,965
-24,379 Reduced 42.38%
33,140 $230,000
Q2 2021

Aug 10, 2021

SELL
$18.46 - $24.36 $19,641 - $25,919
-1,064 Reduced 1.82%
57,519 $1.37 Million
Q1 2021

May 10, 2021

BUY
$17.66 - $28.92 $461,967 - $756,518
26,159 Added 80.68%
58,583 $1.21 Million
Q4 2020

Feb 08, 2021

BUY
$23.25 - $37.73 $567,579 - $921,064
24,412 Added 304.69%
32,424 $795,000
Q3 2020

Nov 06, 2020

BUY
$3.74 - $28.74 $29,964 - $230,264
8,012 New
8,012 $226,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.